Illinois General Assembly - Bill Status for SB2131

Synopsis As Introduced
Amends the Pharmacy Practice Act. Provides that pharmacists may not interchange an atypical anti-psychotic drug or targeted immune modulator without notification and documented consent by the prescribing practitioner and the patient or patient's parent, legal guardian, or spouse. Provides that if the pharmacist does substitute a drug, then the pharmacist shall provide written notice to the patient no later than the time the prescription is dispensed. Provides that these provisions shall not be construed to prohibit generic drug substitution as provided for in the Pharmacy Practice Act. Effective immediately.

Actions

Date	Chamber	Action
5/6/2015	Senate	Filed with Secretary by Sen. Dan Kotowski
5/6/2015	Senate	First Reading
5/6/2015	Senate	Referred to Assignments
1/10/2017	Senate	Session Sine Die

×